CVI Investments, Inc. 13D and 13G filings for Cocrystal Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-16 09:46 am Sale | 2020-12-31 | 13G | Cocrystal Pharma, Inc. COCP | CVI Investments, Inc. | 0 0.000% | -288,462 (Position Closed) | Filing |
2020-03-06 09:25 am Purchase | 2020-02-27 | 13G | Cocrystal Pharma, Inc. COCP | CVI Investments, Inc. | 288,462 7.300% | 288,462 (New Position) | Filing |